Pharma Efforts to Bar Placebo Responders from Trials – WSJ Fri, 25 Jun 2004 A clinical trial report in The Lancet debunks the value of Aricept, a popular drug prescribed for Alzheimer’s patients. The findings of a three-year placebo controlled trial show that: “Although the patients taking the drug did…
ADHD drug – Cylert withdrawn from market due to Liver Toxicity, a Major Risk of Psychotropic Drugs Tue, October 25, 2005 The FDA announced that another drug prescribed for ADHD–Cylert–was removed from the US market for safety reasons. On September 25, 2005, the Associated Press reported: “Eli Lilly said it…
Leading Antipsychotic Drugs Come Under New Scrutiny – NYT Tuesday, May 20, 2003 A front page article in The New York Times reveals that the pillars of American psychiatry–including Dr. Jeffrey Lieberman, Dr. John Kane, Dr. William Carpenter–are acknowledging that evidence is lacking to support the claims that the new…
An Open Letter to Officials of the National Institute of Mental Health Fri, 30 Apr 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org From: Vera Hassner Sharav, President David Cohen, Ph.D. Secretary The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) To: Thomas Insell, MD,…
Landmark Decision: Jury awards $635,177 Damages for Memory Loss from Electroshock Fri, 8 Jul 2005 Below is a press release by Linda Andre, president of Committee for Truth in Psychiatry (CTIP) about the first ever lawsuit in which a jury found a psychiatrist who referred a patient for intensive electroshock…
Statin-Cholesterol Guidelines–Industry influenced? Wed, 14 Jul 2004 Scientific journal editors are scrambling about how to react to bad publicity emanating from public disclosure that the scientific reports they have published are likely to be biased because the authors’ had financial ties to the companies whose drugs / devices they report…
AIDS vaccine Worse Than Useless?_ISS Wed, 25 Jun 2003 An article published by the Institute of Science and Society (ISS locatedin the UK) cautions that experience thus far with 51 NIH-sponsored AIDSvaccinetrials (Phase I and II) belie the claimed positive findings made in anarticle in the currentissue of Vaccine, which…
What’s in a Warning? Antidepressants and Risk of Suicide – FindLaw Thu, 22 Apr 2004 Contrary to the published reports in the peer-reviewed journals, the preponderance of evidence demonstrates that antidepressants pose a greater risk than a benefit for children. *[References below] Informed medical treatment decisions hinge on the decision…
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent Tue, 26 Jul 2005 Patients the world over need adeaquate protection from overreaching physicians who use patients to test experimental drugs and procedures without their informed consent. Jacques Michel, a retired director of Hadassah Hospital in Jerusalem who also…
Pfizer Admits Guilt in Promotion of Neurontin–Agrees to Pay $430 Million Sun, 16 May 2004 A lawsuit initiated by Dr. David Franklin, a whistleblower, has been settled: Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. This case is but an example…
To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s infomails At FDA, Graham is still the whistle-blower Loss of Trust: Big Drug Makers See Sales Decline With Their Image War hero’s death in clinical trial follows years of FDA neglect European perspective:…
Time to put drug giants on trial – Scotsman (UK) Fri, 20 Jun 2003 The UK media-including BBC, the Guardian, the Scotsman, the London Times, and others–have been informing the British public about the hidden health hazards underlying the industry-controlled drug approval and drug marketing process. Current practices have led…
